GlobalAutoimmune Disease Diagnostics Market: Information by Disease Type (SystemicAutoimmune Disease and Others), Localized Autoimmune Disease (Dot Blot, andLine Blot), End-User (Hospitals, Diagnostics Centers and Others ) - GlobalForecast till 2027
AutoimmuneDisease Diagnostics Market - Highlights
Autoimmunedisease is a disorder where body’s own immune system starts attacking thehealthy cells instead of foreign particles and disease-causing agents. Therising awareness about autoimmune disorders, technological advancement in thehealthcare sector and rise in number of cases of autoimmune diseases are thefactors driving the growth of the global autoimmune disease diagnostics market.Moreover, strategic collaborations and aggressive strategies by major playersare also contributing to the growth of the market. For instance, in May 2018,Myriad Genetics, Inc. has acquired Counsyl, Inc. for USD 375 million, Counsylis a global leader in genetic testing and personalized medicine segment.
AutoimmuneDisease Diagnostics Market Segmentation
TheMarket Research Future Report provides an inclusive segmental analysis of theglobal autoimmune disease diagnostics market based on end user, test type,and disease type.
Bydisease type, the autoimmune disease diagnostics market is segmentedinto localized autoimmune disease and systematic autoimmune disease.Systematic autoimmune disease is again segmented into systematic lupuserythematosus (SLE), rheumatoid arthritis, multiple sclerosis, psoriasis, andothers. Localized autoimmune diseases are again segmented into type 1 diabetes,thyroid, inflammatory bowel disease, and others.
By testtype, the autoimmune disease diagnostics market is segmentedinto agglutination, multiplex immunoassay, immunofluorescence assays(IFA), line blot, counter immune-electrophoresis, dot blot, double immunediffusion, enzyme-linked immunosorbent assay (ELISA), western blotting, andothers.
By enduser, the autoimmune disease diagnostics market is segmented into researchlaboratories, diagnostic centers, hospitals, and others.
AutoimmuneDisease Diagnostics Market Regional Analysis
Byregion, the global autoimmune disease diagnostics market covers the growthopportunities and recent trends across Europe, the Americas, the Asia Pacific(APAC), and the Middle East and Africa (MEA). Of these, the Americas will havethe lions share in the market over the forecast period. Factors propelling theautoimmune disease diagnostics market growth in the region include the adoptionof advanced technology, rising financial support from the government as well asprivate organizations, and rising incidence of various autoimmune diseases,especially rheumatoid arthritis.
Theglobal autoimmune disease diagnostics market in Europe is predicted to hold thesecond-largest share over the forecast period for aggressive strategies adoptedby leading industrial players, growing healthcare industry, and risingautomation in laboratories.
Theautoimmune disease diagnostics market in the APAC region is predicted to growat a fast pace over the forecast period. Factors propelling the autoimmunedisease diagnostics market growth in the region include rising private-publicpartnerships to improve the healthcare sector, increasing incidence of autoimmunedisorders, and rising population.
BrowseMore Details at: https://www.marketresearchfuture.com/reports/autoimmune-disease-diagnostics-market-6715
Theautoimmune disease diagnostics market in the MEA is predicted to have a smallshare during the forecast period for poor medical facilities, lack of technicalknowledge, and an underdeveloped healthcare sector.
RELATEDREPORTS
Global Wound Closure Device Market ResearchReport- Forecast to 2027
Contraceptive Pills Market ResearchReport- Global Forecast To 2027
Dermatology Diagnostic deviceMarket Research Report- Global Forecast To 2027
AutoimmuneDisease Diagnostics Market Key Players
Leadingplayers profiled in the global autoimmune disease diagnostics market reportinclude Trinity Biotech Plc., Hemagen Diagnostics, Inc., Myriad Genetics, Inc.,F. Hoffmann-la Roche, Inc., EUROIMMUN AG, AstraZeneca, Bio-rad Laboratories,Inova Diagnostics, Siemens Healthcare Private Limited, Beckman Coulter, Inc.,BioMérieux SA, and Thermo Fisher Scientific.
